Mode
Text Size
Log in / Sign up
N/A Completed N=3,776

Drug Utilization Study on the Prescribing Indications for Yasmin® and Other OCs in Croatia

Source: ClinicalTrials.gov NCT01319500 ↗
Enrolled (actual)
3,776
Serious AEs
—
Results posted
Nov 2012
Primary outcomePrimary: OC Prescriptions by Treatment Group and Prescribing Medical Specialists — 244; 331; 929; 2213 Prescribing physicians

Summary

This study investigates the drug utilization pattern of Oral Contraceptives (OC) in Croatia. Gynecologists and Dermatologists were asked to contribute OC prescribing data to this study.

Outcome Measures

OutcomeResultp-value
PRIMARY
OC Prescriptions by Treatment Group and Prescribing Medical Specialists
244; 331; 929; 2213; 14; 45 —
PRIMARY
Reasons for OC Prescriptions
53.8; 57.8; 38.8; 29.7; 5.2; 11.6 —
PRIMARY
Non-contraceptive Reasons for OC Prescriptions (Reported by Women Who Used OCs for "Contraceptive and Non-contraceptive" and "Non-contraceptive Only" Reasons
226; 338; 212; 246; 199; 405 —
PRIMARY
Non-contraceptive Reasons for OC Prescriptions (Reported by Women Who Used OCs for Non-contraceptive Reasons Only)
29; 131; 22; 97; 15; 40 —
PRIMARY
Reasons for OC Prescriptions by Gynecologists and Dermatologists
2130; 347; 1783; 5; 2135; 1201 —

Eligibility Criteria

Inclusion Criteria

  • women with an OC prescription during the timeframe (Feb-March 2011)
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT01319500). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.

Back to search